Pictet Asset Management
MURA

Pictet Asset Management’s Mural Oncology MURA Stock Holding History

Pictet Asset Management’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-281,955
Closed -$1.67M – 2006
2023
Q4 		$1.67M Buy
+281,955
New +$1.13M ﹤0.01% 912

Other funds holding MURA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pictet Asset Management's MURA Position: Q1 2024 in Review

Pictet Asset Management sold out of Mural Oncology (MURA) in Q1 2024, closing a stake of 281,955 shares — an estimated $1.67M sold.

Pictet Asset Management first reported a position in MURA in Q4 2023 and held it in 1 quarter. The position peaked at $1.67M in Q4 2023. 101 funds tracked by Wall St. Rank hold MURA as of Q1 2024.

  • Pictet Asset Management reported no remaining Mural Oncology position as of Q1 2024 after selling out during the quarter.
  • Pictet Asset Management sold 281,955 Mural Oncology shares in Q1 2024, an estimated $1.67M.
  • Pictet Asset Management first reported a position in Mural Oncology in Q4 2023 and held it in 1 quarter.
  • Pictet Asset Management's Mural Oncology position peaked at $1.67M in Q4 2023.
  • 101 funds tracked by Wall St. Rank held Mural Oncology as of Q1 2024.

Based on Pictet Asset Management's 13F filing for Q1 2024, filed 14 May 2024.